FDA OKs Amitiza for treatment of IBS-C
Wednesday, April 30, 2008 - 13:42
in Health & Medicine
WASHINGTON, April 30 (UPI) -- The U.S. Food and Drug Administration announced approval of Amitiza (lubiprostone) to treat constipation associated with irritable bowel syndrome.